All of the product reviews listed on this website are real reviews from real users. Recommended brands are selected solely based on merit. Our vetting process includes analysis of product quality based on third party lab reports, customer service quality and responsiveness, industry reputation, company longevity and customer feedback. Per FTC guidelines, we do participate in the affiliate programs of some but not all of the recommended brands whereby we receive a small commission on purchases made through links on this website. Any references to third party products, prices or websites referenced in this group are subject to change without notice.
Cunha et al. reported a 2-phase pilot study of CBD versus placebo in normal volunteers and patients with refractory secondarily generalized epilepsy (14). In the first phase, 8 normal volunteers received CBD or placebo in a doubled-blind fashion, at a dose of 3 mg/kg for 30 days. The second phase was also double-blinded in 15 patients with epilepsy receiving 200 to 300 mg daily of CBD or placebo for 135 days. Patients continued baseline AED. All subjects tolerated CBD well, with no serious adverse events. Four of the epilepsy patients receiving CBD were “almost free of convulsive crisis” for the duration of the study. Three other patients receiving CBD had a partial reduction in seizures, and 1 subject had no response. Of the 7 patients receiving placebo, seizure frequency was unchanged in 6, and 1 had clear improvement in seizure control.
ADHD, or attention deficit disorder, with or without hyperactivity, is often first noticed and diagnosed in school-aged children (it is the most commonly diagnosed neurodevelopmental disorder of childhood). Many sufferers must learn to adapt to difficulties in paying attention, remembering seemingly simple tasks, being over-compulsive and more, over the long term. (44)
Other pain: There is also pain that doesn’t fit into either category. The so-called ‘other pain’ arises from neurologic dysfunction, not damage. It is often unexplained or not yet understood. Other pain may also be referred to as sociopathic, allopathic, centralized, or primary pain. Examples of other pain include fibromyalgia, chronic primary headaches, complex regional pain syndrome (CRPS), non-specified chronic low-back pain, irritable bowel syndrome.
‘In doses used as a food supplement, CBD poses few risks, and side effects are unusual but can include a dry mouth or drowsiness,’ reveals Dr Brewer. ‘Higher doses used medically are well tolerated, and there are no serious safety concerns. A World Health Organization report issued in 2017 concluded that cannabidiol does not appear to have abuse potential or cause harm.'
Also listed among our low potency products is our bestselling CanChew® gum. With just 10 mg of CBD per piece of gum, it is easy to get started with CBD as a supplement, and adding more CBD to your diet is as simple as chewing another piece of gum. Another approachable product for those just starting out with CBD, CanChew® gum is a simple delivery method for getting your daily CBD.
This is why Amanda Oliver, 31, a career consultant in Charleston, SC, pops a CBD gummy bear each night before bed. “I used to lie there tossing and turning as my mind raced from work projects to whether I had set the home alarm,” Oliver says. One piece of candy with 15 milligrams (mg) of CBD is enough to shut off her brain and facilitate sleep. She also swears by the CBD oil she takes at the height of her period, which she says quells her debilitating cramps.
At present, we have the following classification of cannabinoids: endocannabinoids (produced naturally in the body, mainly from fatty acid precursors), phytocannabinoids (compounds that have a plant origin, with the cannabis plant being the best-studied source of phytocannabinoids though not the only one), and artificial cannabinoids (created while studying THC, to garner the benefits of marijuana without the recreational component).
Current studies, including one carried out by the UC San Diego School of Medicine, are looking into how the endocannabinoid system may be linked to reducing symptoms associated with autism. This is due to its role in social reward responsivity, neural development and circadian rhythm and anxiety regulation – all of which are often affected by autism. (52)
CBD may offer an option for treating different types of chronic pain. A study from the European Journal of Pain showed, using an animal model, CBD applied on the skin could help lower pain and inflammation due to arthritis. Another study demonstrated the mechanism by which CBD inhibits inflammatory and neuropathic pain, two of the most difficult types of chronic pain to treat. More study in humans is needed in this area to substantiate the claims of CBD proponents about pain control.
Conventional treatment options are not only expensive but often ineffective. Pain medications comes with side effects, health risks, and toxicity that may lead to further pain and health issues. It is often safer and more effective to try natural methods of pain relief, such as an anti-inflammatory diet, stress-reduction strategies, exercise, and bodywork.
Another field in which CBD is creating a buzz is in the area of mood disorders like anxiety and depression. Both conditions have been treated with a variety of medications, courtesy of Big Pharma, that have had varying levels of success. Again, the long list of side effects can be off-putting to someone who just wants to get through the day without the sweaty tension of anxiety or the gray haze of depression.